Vaerlose, Denmark

Soren Berg Padkjaer



Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 45(Granted Patents)


Location History:

  • Værløse, DK (2012)
  • Vaerlose, DK (2013 - 2016)

Company Filing History:


Years Active: 2012-2016

where 'Filed Patents' based on already Granted Patents

6 patents (USPTO):

Title: Soren Berg Padkjaer: Innovator in Monoclonal Antibody Development

Introduction

Soren Berg Padkjaer is a notable inventor based in Vaerlose, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 6 patents to his name, Padkjaer's work has the potential to impact therapeutic applications in humans.

Latest Patents

Among his latest patents is the invention of a humanized anti-human NKG2A monoclonal antibody. This invention relates to agents that act as non-competitive antagonists of the CD94/NKG2A receptor, including specific anti-NKG2A antibodies. Notably, it features humanized versions of the murine anti-NKG2A antibody Z199, along with methods for producing and utilizing these agents. Another significant patent involves humanized antibodies against human interferon-alpha. This invention provides humanized anti-human IFN-α monoclonal antibodies that are useful for therapeutic applications in humans, particularly humanized versions of murine antibodies ACO-1 and ACO-2.

Career Highlights

Soren Berg Padkjaer has worked with prominent companies in the biotechnology sector, including Argos Therapeutics, Inc. and Novo Nordisk A/S. His experience in these organizations has contributed to his expertise in the development of innovative therapeutic solutions.

Collaborations

Padkjaer has collaborated with notable colleagues such as Lars Anders Svensson and Birgitte Friedrichsen. These partnerships have likely enhanced his research and development efforts in the field of monoclonal antibodies.

Conclusion

Soren Berg Padkjaer is a distinguished inventor whose work in monoclonal antibody development showcases his innovative spirit and dedication to advancing biotechnology. His contributions have the potential to lead to significant advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…